Related Experiment Video
Updated: Jun 26, 2026

Behavioral Tasks for Examining Identity Recognition In Mice
Published on: February 7, 2025
Hsp receptors: the cases of identity and mistaken identity
1University of Pittsburgh School of Medicine, E1051, BSTWR, Department of Immunology, 200 Lothrop Street, Pittsburgh, PA 15261, USA. rjb42@pitt.edu
Abstract:
Immune responses elicited by Hsps have been harnessed for the therapy of cancer. Hsps may also play a physiological role in the transfer of antigens in the form of peptides between cells during the event known as cross priming. To elicit these immune responses, Hsps engage antigen-presenting cells through their cell surface receptors. Various molecules have been suggested as Hsp receptors since their existence was first proposed 13 years ago. This review critically examines the literature on Hsp receptors and highlights the experimental evidence that has been provided or is lacking for each molecule. Two phase III clinical trials conducted with Hsp-based vaccines in patients with melanoma or renal cell carcinoma are also discussed.
Insights
Heat shock proteins (Hsps) are crucial for cancer therapy and antigen transfer via cross-priming. This review examines potential Hsp receptors and their roles in immune responses, discussing clinical trials for cancer vaccines.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Heat shock proteins (Hsps) are implicated in cancer therapy and antigen presentation.
- Hsps facilitate cross-priming, a process involving intercellular antigen transfer.
- The precise molecular identity of Hsp receptors remains under investigation.
Purpose of the Study:
- To critically review the literature on proposed Heat shock protein (Hsp) receptors.
- To evaluate the experimental evidence supporting or refuting various Hsp receptor candidates.
- To discuss the implications of Hsp receptor research in cancer immunotherapy.
Main Methods:
- Literature review of studies investigating Hsp-receptor interactions.
- Analysis of experimental data supporting or contradicting proposed Hsp receptors.
- Discussion of clinical trial outcomes for Hsp-based cancer vaccines.
Main Results:
- Several molecules have been proposed as Hsp receptors, but conclusive evidence is often lacking.
- Heat shock proteins (Hsps) engage antigen-presenting cells via cell surface receptors to elicit immune responses.
- Phase III clinical trials for Hsp-based vaccines in melanoma and renal cell carcinoma are ongoing.
Conclusions:
- Further research is needed to definitively identify Hsp receptors and their mechanisms of action.
- Understanding Hsp-receptor interactions is critical for optimizing Hsp-based cancer immunotherapies.
- Hsp-based vaccines show promise in clinical trials for specific cancer types.
Related Concept Videos
Role-Based Identity
Deindividuation
Personal Identity
Dissociative Identity Disorder
Social Identity
Drug toxicity: Idiosyncratic Reactions

